3 completed, 1 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Vehicle Gel: new trials by email Literature Review of Vehicle Gel trials Research Report on Vehicle Gel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients Selinexor, Standard-of-Care, Vehicle Gel - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Withdrawn | Karyopharm Therapeutics Inc | 2015-01-01 | 2023-01-20 | |
| A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris SB204, Vehicle Gel - Acne Vulgaris | Phase 1 | Completed | Novan, Inc. | 18 | 2014-06-01 | 2015-04-03 |
| A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel NVN1000 4% Gel, Vehicle Gel - Acne Vulgaris | Phase 1 | Completed | Novan, Inc. | 30 | 2013-04-01 | 2018-11-19 |
| W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers clindamycin1%/tretinoin 0.025% gel, vehicle gel - Acne Vulgaris | Phase 1 | Completed | GlaxoSmithKline | 64 | 2008-11-21 | 2017-07-18 |
Acne Vulgaris (3) · Diabetes Mellitus (1) · Diabetic Foot (1) · Foot Ulcer (1)
Novan, Inc. (2) · GlaxoSmithKline (1) · Karyopharm Therapeutics Inc (1)
United States (2) · New Zealand (1)
Carlos Sanabria, MD (1) · Joyce Rico, MD (1)